Drugs / Odyliresin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02977832 | Jan 2015 → Jul 2016 | benign prostatic hyperplasia | Fondazione IRCCS Policlinico San Matteo di Pavia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Odyliresin | “Odyliresin (Iresine Celosia) is a cytochrome-flavoprotein with a powerful anti-oxydant action on cells” NCT02977832 ↗ |
| Known as | Iresine Celosia | “Odyliresin (Iresine Celosia) is a cytochrome-flavoprotein with a powerful anti-oxydant action on cells” NCT02977832 ↗ |